Successful Treatment of a Pediatric Neurotrophic Keratopathy With Cenegermin

被引:9
|
作者
Papadopoulos, Kosmas [1 ]
Besgen, Volker [1 ]
Sekundo, Walter [1 ]
机构
[1] Philipps Univ Marburg, Fac Med, Dept Ophthalmol, Baldingerstr, D-35043 Marburg, Germany
关键词
cenegermin; pediatric neurotrophic keratopathy; child; cornea; OUTCOMES;
D O I
10.1097/ICO.0000000000002512
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: We present a challenging case of a 9-year-old patient with refractory neurotrophic keratopathy (NK) who was successfully treated with cenegermin eye drops. Methods: A 7-year-old boy developed an ocular infection after a visit to a public swimming pool. After having been unsuccessfully treated for 2 years with antibiotics, steroids, and artificial tears, the patient presented to our clinic with a therapy-refractory NK. We initiated treatment with autologous serum eye drops that showed only weak response. Therefore, treatment with cenegermin eye drops was started. Results: After cenegermin therapy, a complete restoration of the corneal surface and an increase in visual acuity were achieved. Conclusions: The use of cenegermin is effective in treating pediatric NK.
引用
收藏
页码:516 / 518
页数:3
相关论文
共 50 条
  • [31] Treatment of neurotrophic keratopathy with nasal dilator strips
    Magone, MT
    Seitzman, GD
    Nehls, S
    Margolis, TP
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2005, 89 (11) : 1529 - 1530
  • [32] Neurotrophic keratopathy
    Dua, Harminder S.
    Said, Dalia G.
    Messmer, Elisabeth M.
    Rolando, Maurizio
    Benitez-del-Castillo, Jose M.
    Hossain, Parwez N.
    Shortt, Alex J.
    Geerling, Gerd
    Nubile, Mario
    Figueiredo, Francisco C.
    Rauz, Saaeha
    Mastropasqua, Leonardo
    Rama, Paolo
    Baudouin, Christophe
    PROGRESS IN RETINAL AND EYE RESEARCH, 2018, 66 : 107 - 131
  • [33] Corneal Neurotization: A Surgical Treatment for Neurotrophic Keratopathy
    Kolseth, Clinton M.
    Charlson, Emily S.
    Kossler, Andrea L.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2020, 40 (02) : E11 - E12
  • [34] New insights into the diagnosis and treatment of neurotrophic keratopathy
    Goins, KM
    OCULAR SURFACE, 2005, 3 (02): : 96 - 110
  • [35] Potential New Modes of Treatment of Neurotrophic Keratopathy
    Yanai, Ryoji
    Nishida, Teruo
    Chikama, Tai-Ichiro
    Morishige, Naoyuki
    Yamada, Naoyuki
    Sonoda, Koh-Hei
    CORNEA, 2015, 34 : S121 - S127
  • [36] Current and experimental treatment approaches for neurotrophic keratopathy
    Alder, J.
    Mertsch, S.
    Menzel-Severing, J.
    Geerling, G.
    OPHTHALMOLOGE, 2019, 116 (02): : 127 - 137
  • [37] Recombinant Human Nerve Growth Factor for Pediatric Neurotrophic Keratopathy
    Niruthisard, Duangratn
    Fung, Simon S. M.
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2022, 48 (07): : 303 - 305
  • [38] Corneal nerve changes on confocal microscopy after cenegermin treatment for neurotrophic keratitis
    Kwan, Changyow
    Kim, Cinthia
    Shi, Yue
    Garg, Sumit
    Lee, Olivia L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [39] Phase IV Multicenter, Prospective, Open-Label Clinical Trial of Cenegermin (rhNGF) for Stage 1 Neurotrophic Keratopathy (DEFENDO)
    Hamrah, Pedram
    Massaro-Giordano, Mina
    Schanzlin, David
    Holland, Edward
    Berdy, Gregg
    Goisis, Giovanni
    Pasedis, Georgea
    Mantelli, Flavio
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (02) : 553 - 570
  • [40] Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy
    Dana, Reza
    Farid, Marjan
    Gupta, Preeya K.
    Hamrah, Pedram
    Karpecki, Paul
    McCabe, Cathleen M.
    Nijm, Lisa
    Pepose, Jay S.
    Pflugfelder, Stephen
    Rapuano, Christopher J.
    Saini, Arvind
    Gibbs, Sarah N.
    Broder, Michael S.
    BMC OPHTHALMOLOGY, 2021, 21 (01)